QIAGEN
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.QIAGEN offers its sample and assay consumable products in kit form.
QIAGEN
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1986-01-01
Address:
Venlo, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.qiagen.com
Total Employee:
1001+
Status:
Active
Contact:
+31 77 320 8400
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-11 | BLIRT | BLIRT acquired by Qiagen | N/A |
| 2020-09-17 | NeuMoDx Molecular | NeuMoDx Molecular acquired by Qiagen | 248 M USD |
| 2019-01-07 | N-of-One | N-of-One acquired by Qiagen | N/A |
| 2018-11-01 | Parsagen | Parsagen acquired by Qiagen | N/A |
| 2018-02-01 | STAT-Dx | STAT-Dx acquired by Qiagen | 191 M USD |
| 2017-01-09 | OmicSoft Corp. | OmicSoft Corp. acquired by Qiagen | N/A |
| 2015-11-01 | MO BIO Laboratories | MO BIO Laboratories acquired by Qiagen | N/A |
| 2014-06-05 | PrimeraDx (Primera Biosystems) | PrimeraDx (Primera Biosystems) acquired by Qiagen | N/A |
| 2014-05-21 | BIOBASE | BIOBASE acquired by Qiagen | N/A |
| 2013-10-25 | CLC bio | CLC bio acquired by Qiagen | N/A |
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Qiagen
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Qiagen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-19 | Glyphic Biotechnologies | Qiagen investment in Grant - Glyphic Biotechnologies | 40 K USD |
| 2021-07-01 | Actome | Qiagen investment in Seed Round - Actome | N/A |
| 2018-03-20 | ArcherDX | Qiagen investment in Series A - ArcherDX | 35 M USD |
| 2016-01-07 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 16 M USD |
| 2014-12-17 | Protagen | Qiagen investment in Venture Round - Protagen | 10 M EUR |
| 2014-03-11 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 27 M USD |
| 2013-01-08 | Drug Response Dx | Qiagen investment in Series A - Drug Response Dx | N/A |
| 2012-01-30 | Xagenic | Qiagen investment in Series A - Xagenic | 10 M USD |
| 1999-08-03 | Coley Pharmaceutical Group | Qiagen investment in Series B - Coley Pharmaceutical Group | 12.9 M USD |
| 1998-06-01 | Ingenium Pharmaceuticals AG | Qiagen investment in Seed Round - Ingenium Pharmaceuticals AG | N/A |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-24 | QIAGEN Names Thierry Bernard as Chief Executive Officer |
Official Site Inspections
http://www.qiagen.com Semrush global rank: 146.6 K Semrush visits lastest month: 591.44 K
- Host name: 20.105.224.28
- IP address: 20.105.224.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Qiagen"
Qiagen - Wikipedia
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research.See details»
Sample to Insight - QIAGEN
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.See details»
Executive Committee - QIAGEN
Meet QIAGEN's Executive Committee, including the CEO, CFO, and key leaders driving the company's strategy, innovation and global impact.See details»
Historical Development - QIAGEN
QIAGEN's journey began in the mid-1980s, the early days of biotechnology as a spin-off of university research. Today some 6,000 employees, based in more than 25 countries, provide …See details»
Our global presence - QIAGEN
Discover QIAGEN's Global Presence QIAGEN operates 35 subsidiaries across over 25 countries, supported by a global distribution partner network spanning more than 60 countries. Our team …See details»
QIAGEN - Leadership Team | The Org
The Leadership Team at QIAGEN is responsible for setting the strategic direction of the company and ensuring the successful execution of its mission in the molecular diagnostics and research …See details»
Qiagen - Crunchbase Company Profile & Funding
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.See details»
Qiagen N.V. - Investor Relations - Corporate Governance
QIAGEN N.V. is a company organized under the laws of the Netherlands and is listed on NYSE and in the Prime Standard Segment of the Frankfurt Stock Exchange in Germany. As such, …See details»
Business and Operating Environment | Financial Report 2019
QIAGEN is a global leader in Sample to Insight solutions that transform biological samples into valuable molecular insights. Our mission is to enable customers across the continuum of …See details»
Corporate Governance Report | Financial Report 2019 - Qiagen
Corporate Structure QIAGEN is a ‘Naamloze Vennootschap,’ or N.V., a Dutch public limited liability company similar to a corporation in the United States. QIAGEN has a two-tier board …See details»
QIAGEN announces plans for transition in leadership of …
4 days ago QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&D and industrial applications, primarily forensics) and Molecular Diagnostics for …See details»
Why QIAGEN
What attracts a talented individual to a global company? Many would say it's the corporate culture and work environment that make all the difference. There is more to QIAGEN, than facts and …See details»
QIAGEN Corporate - Bioinformatics Software | QIAGEN Digital …
To this end, QIAGEN offers you innovative solutions that cover every single step along this journey – not just technologies, but bridges from samples to insights. QIAGEN offers you the …See details»
株式会社キアゲン QIAGENについて
QIAGENグループの日本法人である株式会社キアゲンは、QIAGEN本社の企業戦略および経営方針との連携を通して、日本国内の幅広いライフサイエンス研究、分子診断分野におい …See details»
Qiagen N.V. - Investor Relations
QIAGEN Deep Dive – QuantiFERON Visit our Deep Dive landing page to learn more about our QuantiFERON franchise with our market-leading latent TB blood test.See details»
A focus on five pillars | Financial Report 2020 - Qiagen
…the pivotal and challenging year 2020… Thomas Schweins QIAGEN shifted gears to play a crucial role in tackling COVID, and we showed how swiftly we can react when faced with …See details»
Business and Operating Environment | Financial Report 2020
Business and Operating Environment QIAGEN is a global leader in Sample to Insight solutions that transform biological samples into valuable molecular insights. Our mission is to enable …See details»
QIAGEN announces plans for transition in leadership of …
3 days ago Mr. Rosen said: "QIAGEN is an exceptional company, and it has been a privilege to serve on the Supervisory Board during a period of transformational growth. Over these years, …See details»
QIAGEN announces plans for transition in leadership of …
4 days ago QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&D and industrial applications, primarily forensics) and Molecular Diagnostics for …See details»
Complete Cancer Research and Oncology Solutions | QIAGEN
Unlock oncology solutions to advance cancer research and diagnostics. Explore workflows for biomarker testing, liquid biopsy, multiomics, precision medicine and more.See details»